CA2303106A1 - Gene polymorphe contenant des unites de repetition cag et ses utilisations - Google Patents

Gene polymorphe contenant des unites de repetition cag et ses utilisations Download PDF

Info

Publication number
CA2303106A1
CA2303106A1 CA002303106A CA2303106A CA2303106A1 CA 2303106 A1 CA2303106 A1 CA 2303106A1 CA 002303106 A CA002303106 A CA 002303106A CA 2303106 A CA2303106 A CA 2303106A CA 2303106 A1 CA2303106 A1 CA 2303106A1
Authority
CA
Canada
Prior art keywords
gene
allelic variants
schizophrenia
patients
neuroleptic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002303106A
Other languages
English (en)
Inventor
Guy A. Rouleau
Ridha Joober
Chawki Benkelfat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2216057 external-priority patent/CA2216057A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002303106A priority Critical patent/CA2303106A1/fr
Publication of CA2303106A1 publication Critical patent/CA2303106A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention porte sur le gène hGT1, un gène polymorphe contenant des unités de répétition CAG et sur ses utilisations dans le diagnostic, le pronostic et le traitement de maladies psychiatriques telles que la schizophrénie.
CA002303106A 1997-09-19 1998-09-18 Gene polymorphe contenant des unites de repetition cag et ses utilisations Abandoned CA2303106A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002303106A CA2303106A1 (fr) 1997-09-19 1998-09-18 Gene polymorphe contenant des unites de repetition cag et ses utilisations

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA2,216,057 1997-09-19
CA 2216057 CA2216057A1 (fr) 1997-09-19 1997-09-19 Gene contenant des microsatellites polymorphiques de type cag, diagnostic de maladies psychiatriques et usages therapeutiques de ce gene
CA002303106A CA2303106A1 (fr) 1997-09-19 1998-09-18 Gene polymorphe contenant des unites de repetition cag et ses utilisations
PCT/CA1998/000884 WO1999015639A1 (fr) 1997-09-19 1998-09-18 Gene polymorphe contenant des unites de repetition cag et ses utilisations

Publications (1)

Publication Number Publication Date
CA2303106A1 true CA2303106A1 (fr) 1999-04-01

Family

ID=25679626

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002303106A Abandoned CA2303106A1 (fr) 1997-09-19 1998-09-18 Gene polymorphe contenant des unites de repetition cag et ses utilisations

Country Status (1)

Country Link
CA (1) CA2303106A1 (fr)

Similar Documents

Publication Publication Date Title
Rietschel et al. Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression
Martucci et al. N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels
Wishart et al. COMT Val158Met genotype and individual differences in executive function in healthy adults
Aoki-Suzuki et al. A family-based association study and gene expression analyses of netrin-G1 and-G2 genes in schizophrenia
Lappalainen et al. Association between alcoholism and γ‐amino butyric acid α2 receptor subtype in a Russian population
Wendland et al. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder
Michelon et al. Association study of the INPP1, 5HTT, BDNF, AP-2β and GSK-3β GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder
Sekiguchi et al. ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk
Radel et al. Haplotype-based localization of an alcohol dependence gene to the 5q34 γ-aminobutyric acid type A gene cluster
Domschke Clinical and molecular genetics of psychotic depression
Gokturk et al. Serotonin transporter (5-HTTLPR) and monoamine oxidase (MAOA) promoter polymorphisms in women with severe alcoholism
US20150278438A1 (en) Genetic predictors of response to treatment with crhr1 antagonists
Joober et al. DRD3 and DAT1 genes in schizophrenia: an association study
Karayiorgou et al. Schizophrenia genetics: uncovering positional candidate genes
US20180275149A1 (en) Method for predicting a subject's response to valproic acid therapy
Melroy et al. Examination of genetic variation in GABRA2 with conduct disorder and alcohol abuse and dependence in a longitudinal study
Vázquez-Bourgon et al. A disrupted-in-Schizophrenia 1 gene variant is associated with clinical symptomatology in patients with first-episode psychosis
Ehret et al. Microdeletions in 9q33. 3-q34. 11 in five patients with intellectual disability, microcephaly, and seizures of incomplete penetrance: is STXBP1 not the only causative gene?
MacDonald III et al. COMT val158Met and executive control: a test of the benefit of specific deficits to translational research.
Rothe et al. Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany
Kennerson et al. X-linked distal hereditary motor neuropathy maps to the DSMAX locus on chromosome Xq13. 1-q21
Park et al. Association of thrombospondin 1 gene with schizophrenia in Korean population
AU757556B2 (en) Polymorphic CAG repeat-containing gene and uses thereof
Papadimitriou et al. Association between GABA-A receptor alpha 5 subunit gene locus and schizophrenia of a later age of onset
Kotaka et al. G72 gene is associated with susceptibility to methamphetamine psychosis

Legal Events

Date Code Title Description
FZDE Discontinued